Cellular growth inhibition by IGFBP‐3 and TGF‐β 1 requires LRP‐1
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The type V TGF‐β receptor (TβR‐V)/IGFBP‐3 receptor mediates the IGF‐independent growth inhibition induced by IGFBP‐3. It also mediates the growth inhibitory response to TGF‐β 1 in concert with other TGF‐β receptor types, and its loss may contribute to the malignant phenotype of human carcinoma cells. Here we demonstrate that TβR‐V is identical to LRP‐1/α 2 M receptor as shown by MALDI‐TOF analysis of tryptic peptides of TβR‐V purified from bovine liver. In addition, 125 I‐IGFBP‐3 affinity‐labeled TβR‐V in Mv1Lu cells is immunoprecipitated by antibodies to LRP‐1 and TβR‐V. RAP, an LRP‐1 antagonist, inhibits binding of 125 I‐TGF‐β 1 and 125 I‐IGFBP‐3 to Tβ R‐V and diminishes IGFBP‐3‐induced growth inhibition in Mv1Lu cells. Absent or low levels of LRP‐1, as with TβR‐V, have been linked to the malignant phenotype of carcinoma cells. Mutagenized Mv1Lu cells selected for reduced expression of LRP‐1 have an attenuated growth inhibitory response to TGF‐β 1 and IGFBP‐3. LRP‐1‐deficient mouse embryonic fibroblasts lack a growth inhibitory response to TGF‐β 1 and IGFBP‐3. On the other hand, stable transfection of H1299 human lung carcinoma cells with LRP‐1 cDNA restores the growth inhibitory response. These results suggest that the LRP‐1/TβR‐V/IGFBP‐3 receptor is required for the growth inhibitory response to IGFBP‐3 and TGF‐β 1 .—Huang, S. S., Ling, T.‐Y., Tseng, W.‐F., Huang, Y.‐H., Tang, F.‐M., Leal, S. M., Huang, J. S. Cellular growth inhibition by IGFBP‐3 and TGF‐β1 requires LRP‐1. FASEB J. 17, 2068–2081 (2003)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G1 arrest
Petritsch, C., Beug, H., Balmain, A., & Oft, M. (2000) · Genes & Development · doi:10.1101/gad.854200 · Cited by 223
Cited by
Senescence-messaging secretome: SMS-ing cellular stress
Kuilman, T., & Peeper, D. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2560 · Cited by 909
Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
Holtzman, D. M., Herz, J., & Bu, G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006312 · Cited by 782
“…with other types of signaling proteins and modules, and thereby modulate their intrinsic activity (Boucher et al. 2002; Loukinova et al. 2002; Huang et al. 2003; Lillis et al. 2008; Zurhove et al. 2008), including that of the N-methyl-D-aspartate (NMDA) receptor (May et al. 2004; Beffert et…”
BackgroundLillis, A. P., Van Duyn, L. B., Murphy-Ullrich, J. E., & Strickland, D. K. (2008) · Physiological Reviews · doi:10.1152/physrev.00033.2007 · Cited by 669
IGF binding proteins in cancer: mechanistic and clinical insights
Baxter, R. C. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3720 · Cited by 525
IGF-Binding Proteins: Why Do They Exist and Why Are There So Many?
Allard, J. B., & Duan, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00117 · Cited by 515
Metadata
- Authors
- Huang, S. S., Ling, T.-Y., Tseng, W.-F., Huang, Y.-H., Tang, F.-M., Leal, S. M., & Huang, J. S.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2003-11
- Volume
- 17
- Issue
- 14
- Pages
- 2068-2081
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2016259832
- Cited by
- 157
- References
- 2
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.